Chronic enteropathy and feeding in children: An update

Nutrition

Volumn 24, Issue 11-12, 2008, Pages 1205-1216

  Salvatore, Silvia ^a   Hauser, Bruno ^b   Devreker, Thierry ^b   Arrigo, Serena ^a   Vandenplas, Yvan ^b  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Celiac disease; Cow's milk allergy; Enteropathy; Food allergy; Gastrointestinal flora; Lipid; Nucleotide; Polyunsaturated fatty acid

Indexed keywords

ACETIC ACID; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID DERIVATIVE; FISH OIL; GLUCONIC ACID; GLUTAMINE; ICOSAPENTAENOIC ACID; INTESTINE ENZYME; LINOLEIC ACID; LINOLENIC ACID; LIPID; MESALAZINE; MONOACYLGLYCEROL; NUCLEOTIDE; ORAL REHYDRATION SOLUTION; PANCREAS ENZYME; RESOLVIN; RIBONUCLEOTIDE; UNCLASSIFIED DRUG; ZINC; ZINC SULFATE;

ALLERGY; ANTIINFLAMMATORY ACTIVITY; BREAST FEEDING; CELIAC DISEASE; CELL MEMBRANE PERMEABILITY; CLINICAL TRIAL; CROHN DISEASE; DIARRHEA; ENTERITIS; ENTEROPATHY; EOSINOPHILIC GASTROINTESTINAL DISORDER; FOOD ALLERGY; GASTROINTESTINAL INFECTION; HUMAN; IMMUNE DYSREGULATION; IMMUNE RESPONSE; INFANT FEEDING; MALNUTRITION; MILK ALLERGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE ACTIVATION;

CELIAC DISEASE; CHILD; CHILD NUTRITIONAL PHYSIOLOGY PHENOMENA; CHILD, PRESCHOOL; DIARRHEA; DIETARY PROTEINS; FEMALE; FOOD HYPERSENSITIVITY; GASTROINTESTINAL TRACT; HUMANS; INFANT; INFANT, NEWBORN; INTESTINAL MUCOSA; MALE; MILK HYPERSENSITIVITY; MILK, HUMAN;

BACTERIA (MICROORGANISMS);

EID: 53449092760     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2008.04.011     Document Type: Review

References (143)

1. Walker-Smith J.A., and Murch S.H. Diseases of the small intestine in childhood. 4th ed. (1999), Isis Medical Media, Oxford
2. Bhutta Z.A., Ghishan F., Lindley K., Memon I.A., Mittal S., Rhoads J.M., and Commonwealth Association of Paediatric Gastroenterology and Nutrition. Persistent and chronic diarrhea and malabsorption: Working Group Report of the Second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 39 (2004) S711-S716
3. Torrente F., and Murch S. Food allergic enteropathy. In: Walker A.W., Goulet O., Kleinman R.E., et al. (Eds). Pediatric gastrointestinal disease. 4th ed. (2004), BC Decker, Hamilton, ON, Canada 944-958
4. Latcham F., Merino F., Lang A., Garvey J., Thomson M.A., Walker-Smith J.A., et al. A consistent pattern of minor immunodeficiency and subtle enteropathy in children with multiple food allergy. J Pediatr 143 (2003) 39-47
5. Doron S., Snydman D.R., Gorbach S.L., and Lactobacillus G.G. bacteriology and clinical applications. Gastroenterol Clin North Am 34 (2005) 483-498
6. Szajewska H., and Mrukowicz J.Z. Use of probiotics in children with acute diarrhea. Pediatr Drugs 7 (2005) 111-122
7. Vandenplas Y., Salvatore S., Viera M., Devreker T., and Hauser B. Probiotics in infectious diarrhoea in children: are they indicated?. Eur J Pediatr 5 (2007) 1211-1218
8. Salvatore S., Hauser B., Devreker T., Vieira M.C., Luini C., Arrigo S., Nespoli L., and Vandenplas Y. Probiotics and zinc in acute infectious gastroenteritis in children: are they effective?. Nutrition 23 (2007) 498-506
9. Galpin L., Manary M.J., Fleming K., Ou C.N., Ashorn P., and Shulman R.J. Effect of Lactobacillus GG on intestinal integrity in Malawian children at risk of tropical enteropathy. Am J Clin Nutr 82 (2005) 1040-1045
10. Dahan S., Dalmasso G., Imbert V., Peyron J.F., Rampal P., and Czerucka D. Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signalling pathways in T84 cells. Infect Immun 71 (2003) 766-773
11. Czerucka D., Dahan S., Mograbi B., Rossi B., and Rampal P. Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells. Infection Immunity 68 (2000) 5998-6004
12. Altwegg M. Influence of Saccharomyces boulardii on cell invasions of Salmonella typhimurium and Yersinia enterocolitica. Microb Ecol Health Dis 11 (1999) 158-162
13. Berni Canani R., and Ruotolo S. The dawning of the zinc era in the treatment of pediatric acute gastroenteritis worldwide?. J Pediatr Gastroenterol Nutr 42 (2006) 253-255
14. Sazawal S., Black R.E., Bhan M.K., Bhandari N., Sinha A., and Jalla S. Zinc supplementation in young children with acute diarrhea in India. N Engl J Med 333 (1995) 839-844
15. Bhutta Z.A., Black R.E., Brown K.H., Gardner J.M., Gore S., Hidayat A., et al. Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. J Pediatr 135 (1999) 689-697
16. Bhutta Z.A., Bird S.M., Black R.E., Brown K.H., Gardner J.M., Hidayat A., et al. Therapeutic effects of oral zinc in acute and persistent diarrhea in children in developing countries: pooled analysis of randomized controlled trials. Am J Clin Nutr 72 (2000) 1516-1522
17. Baqui A.H., Black R.E., El Arifeen S., Yunus M., Chakraborty J., Ahmed S., and Vaughan J.P. Effect of zinc supplementation started during diarrhea on morbidity and mortality in Bangladeshi children: community randomized trial. BMJ 325 (2002) 1059-1063
18. Bobat R., Coovadia H., Stephen C., Naidoo K.L., McKerrow N., Black R.E., and Moss W.J. Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomised double-blind placebo-controlled trial. Lancet 366 (2005) 1862-1867
19. INCLEN Childnet Zinc Effectiveness for Diarrhoea Group. Zinc supplementation in acute diarrhea is acceptable, does not interfere with oral rehydration and reduces the use of other medications: a randomized trial in five countries. J Pediatr Gastroenterol Nutr 42 (2006) 300-305
20. WHO/UNICEF. WHO/UNICEF joint statement: clinical management of acute diarrhoea (2004), United Nations Children's Fund/Geneva, New York Switzerland: World Health Organization; p. 1-8
21. Hill D.I., Dirks M.H., Liptak G.S., Colletti R.B., Fasano A., Guandalini S., et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 40 (2005) 1-19
22. Troncone R., Bhatnagar S., Butzner D., Cameron D., Hill I., Hoffenberg E., et al. Celiac disease and other immunologically mediated disorders of the gastrointestinal tract: Working Group Report of the Second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 39 (2004) S601-S610
23. Vitoria J.C., Camarero C., Sojo A., Ruiz A., and Rodriguez-Soriano J. Enteropathy related to fish, rice, and chicken. Arch Dis Child 57 (1982) 44-48
24. Nowak-Wegrzyn A., Sampson H.A., Wood R.A., and Sicherer S.H. Food protein-induced enterocolitis syndrome caused by solid food proteins. Pediatrics 111 (2003) 829-835
25. Rozenfeld P., Docena G.H., Anon, and Fossati C.A. Detection and identification of a soy protein component that cross-reacts with caseins from cow's milk. Clin Exp Immunol 130 (2002) 49-58
26. Zeiger R.S., Sampson H.A., and Bock S.A. Soy allergy in infants and children with IgE-associated cow's milk allergy. J Pediatr 134 (1999) 614-622
27. Klemola T., Vanto T., Juntunen-Backman K., Kalimo K., Korpela R., and Varjonen E. Allergy to soy formula and to extensively hydrolyzed whey formula in infants with cows' milk allergy: a prospective, randomized study with a follow-up to the age of 2 years. J Pediatr 140 (2002) 219-224
28. Murch S.H. The immunologic basis for intestinal food allergy. Curr Opin Gastroenterol 16 (2000) 552-557
29. Kokkonen J., Haapalahti M., Laurila K., Karttunen T.J., and Mäki M. Cow's milk protein sensitive enteropathy at school age. J Pediatr 139 (2001) 797-803
30. Kokkonen J., Tikkanen S., Karttunen T.J., and Savilahti E. A similar high level of immunoglobulin A and immunoglobulin G class milk antibodies and increment of local lymphoid tissue on the duodenal mucosa in subjects with cow's milk allergy and recurrent abdominal pains. Pediatr Allergy Immunol 13 (2002) 129-136
31. Hill D.J., Ball G., Hoskings C.S., and Wood P.R. Gamma-interferon production in cow's milk allergy. Allergy 48 (1993) 75-80
32. Pérez-Machado M.A., Ashwood P., Thomson M.A., Latcham F., Sim R., Walker-Smith J.A., and Murch S.H. Reduced transforming growth factor-beta1 producing T cells in the duodenal mucosa of children with food allergy. Eur J Immunol 33 (2003) 2307-2315
33. Nagata S., Yamashiro Y., Ohtsuka Y., Shioya T., Oguchi S., Shimizu T., and Maeda M. Quantitative analysis and immunohistochemical studies on small intestinal mucosa of food-sensitive enteropathy. J Pediatr Gastroenterol Nutr 20 (1995) 44-48
34. Collins S.M. The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology 111 (1996) 1683-1699
35. Savilahti E. Food-induced malabsorption syndromes. J Pediatr Gastroenterol Nutr 30 suppl (2000) S61-S66
36. Schappi M.G., Smith V.V., Cubitt D., Milla P.J., and Lindley K.J. Faecal elastase 1 concentration is a marker of duodenal enteropathy. Arch Dis Child 86 (2002) 50-53
37. Caramalho I., Lopes-Carvalho T., Ostler D., Zelenay S., Haury M., and Demengeot J. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 197 (2003) 403-411
38. Hooper L.V., and Gordon J.I. Commensal host-bacterial relationships in the gut. Science 292 5519 (2001) 1115-1118
39. Bjorksten B., Sepp E., Julge K., Voor T., and Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 108 (2001) 516-520
40. Ouwehand A.C., Isolauri E., He F., Hashimoto H., Benno Y., and Salminen S. Differences in Bifidobacterium flora composition in allergic and healthy infants. J Allergy Clin Immunol 108 (2001) 144-145
41. Kalliomaki M., Salminen S., Poussa T., Arvilommi H., and Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361 (2003) 1869-1871
42. Lodinova-Zadnikova R., Cukrowska B., and Tlaskalova-Hogenova H. Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years). Int Arch Allergy Immunol 131 (2003) 209-211
43. Boehm G., Lidestri M., Casetta P., Jelinek J., Negretti F., Stahl B., and Marini A. Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of fecal bifidobacteria in preterm infants. Arch Dis Child Fetal Neonatal Ed 86 (2002) F178-F181
44. Moro G., Minoli I., Mosca M., Fanaro S., Jelinek J., Stahl B., and Boehm G. Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants. J Pediatr Gastroenterol Nutr 34 (2002) 291-295
45. Schmelzle H., Wirth S., Skopnik H., Radke M., Knol J., Böckler H.M., et al. Randomized double-blind study of the nutritional efficacy and bifidogenicity of a new infant formula containing partially hydrolyzed protein, a high betapalmitic acid level, and nondigestible oligosaccharides. J Pediatr Gastroenterol Nutr 36 (2003) 343-351
46. Knol J., Scholtens P., Kafka C., Steenbakkers J., Gro S., Helm K., et al. Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infants. J Pediatr Gastroenterol Nutr 40 (2005) 36-42
47. Moro G., Arslanoglu S., Stahl B., Jelinek J., Wahn U., and Boehm G. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child 91 (2006) 814-819
48. Salvatore S., Keymolen K., Hauser B., and Vandenplas Y. Intervention during pregnancy and allergic disease in the offspring. Pediatr Allergy Immunol 16 (2005) 558-566
49. Vandenplas Y. The use of hydrolysates in allergy prevention programmes. Eur J Clin Nutr 49 suppl 1 (1995) S84-S91
50. Halken S., Hansen K.S., Jacobsen H.P., Estmann A., Faelling A.E., Hansen L.G., et al. Comparison of a partially hydrolyzed infant formula with two extensively hydrolyzed formulas for allergy prevention: a prospective, randomized study. Pediatr Allergy Immunol 11 (2000) 149-161
51. OldÆus G., Anjou K., Björkstén B., Moran J.R., and Kjellman N.I. Extensively and partially hydrolysed infant formulas for allergy prophylaxis. Arch Dis Child 77 (1997) 4-10
52. Von Berg A., Koletzo S., Grubl A., Filipiak-Pittroff B., Wichmann H.E., Bauer C.P., et al. The effect of hydrolyzed cow's milk formula for allergy prevention in the first year of life: the German Infant Nutritional Intervention Study, a randomized double-blind trial. J Allergy Clin Immunol 111 (2003) 533-540
53. American Academy of Pediatrics, Committee on Nutrition. Hypoallergenic infant formulas. Pediatrics 106 (2000) 346-349
54. Host A., Koletzko B., Dreborg S., Muraro A., Wahn U., Aggett P., et al. Joint statement of the European Society for Paediatric Allergology and Clinical Immunology (ESPACI) Committee on Hypoallergenic Formulas and the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) Committee on Nutrition. Arch Dis Child 81 (1999) 80-84
55. Halken S. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention. Pediatr Allergy Immunol 15 suppl 16 (2004) 9-32
56. Muraro A., Dreborg S., Halken S., Høst A., Niggemann B., Aalberse R., et al. Dietary prevention of allergic diseases in infants and small children. Part III: critical review of published peer-reviewed observational and interventional studies and final recommendations. Pediatr Allergy Immunol 15 (2004) 291-307
57. Vandenplas Y., Koletzko S., Isolauri E., Hill D., Oranje A.P., Brueton M., Staiano A., and Dupont C. Guidelines for the diagnosis and management of cow's milk protein allergy in infants. Arch Dis Child 92 (2007) 902-908
58. Hill D.J., Heine R.G., Cameron D.J., Francis D.E., and Bines J.E. The natural history of intolerance to soy and extensively hydrolyzed formula in infants with multiple food protein intolerance. J Pediatr 135 (1999) 118-121
59. Klemola T., Savilahti E., Arato A., Ormälä T., Partanen J., Eland C., and Koskimies S. Immunohistochemical findings in jejunal specimens from patients with IgA deficiency. Gut 37 (1995) 519-523
60. McLoughlin L.C., Nord K.S., Joshi V.V., Oleske J.M., and Connor E.M. Severe gastrointestinal involvement in children with the acquired immunodeficiency syndrome. J Pediatr Gastroenterol Nutr 6 (1987) 517-524
61. Cárcamo C., Hooton T., Wener M.H., Weiss N.S., Gilman R., Arevalo J., et al. Etiologies and manifestations of persistent diarrhea in adults with HIV-1 infection: a case-control study in Lima, Peru. J Infect Dis 191 (2005) 11-19
62. Kotler D.P. HIV infection and the gastrointestinal tract. AIDS 19 (2005) 107-117
63. Wittenberg D., Benitez C.V., Canani R.B., Hadigan C., Perin N.M., Rabinowitz S., Ukarapol N., and Commonwealth Association of Paediatric Gastroenterology and Nutrition. HIV infection: working group report of the second world congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 39 (2004) S640-S646
64. Rothenberg M.E. Eosinophilic gastrointestinal disorders. J Allergy Clin Immunol 113 (2004) 11-28
65. MacDonald T.T., and Monteleone G. Immunity, inflammation, and allergy in the gut. Science 307 (2005) 1920-1925
66. Campos F.G., Waitzberg D.L., Teixeira M.G., Mucerino D.R., Kiss D.R., and Habr-Gama A. Pharmacological nutrition in inflammatory bowel diseases. Nutr Hosp 18 (2003) 57-64
67. Newby E.A. Interventions for growth failure in childhood Crohn's disease. Cochrane Database Syst Rev 3 (2005) CD003873.
68. Beattie R.M. Enteral nutrition as primary therapy in childhood Crohn's disease: control of intestinal inflammation and anabolic response. JPEN 29 suppl (2005) S151-S155
69. Heuschkel R. Enteral nutrition in Crohn disease: more than just calories. J Pediatr Gastroenterol Nutr 38 (2004) 239-241
70. De Jong N., Leach S., and Day A. Polymeric formula can act on the NF-kappaB pathway to limit inflammation in an in vitro model of intestinal inflammation. J Pediatr Gastroenterol Nutr 42 (2006) E43
71. Fell J.M. Control of systemic and local inflammation with transforming growth factor beta containing formulas. JPEN 29 suppl (2005) S126-S128
72. Lionetti P., Callegari M.L., Ferrari S., Cavicchi M.C., Pozzi E., de Martino M., and Morelli L. Enteral nutrition and microflora in pediatric Crohn's disease. JPEN 29 suppl (2005) S173-S175
73. Johnson T. Treatment of active Crohn's disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial. Gut 55 (2006) 356-361
74. Afzal N.A., Davies S., Paintin M., Arnaud-Battandier F., Walker-Smith J.A., Murch S., et al. Colonic Crohn's disease in children does not respond well to treatment with enteral nutrition if the ileum is not involved. Dig Dis Sci 50 (2005) 1471-1475
75. Mac Lean C.H., Mojica W.A., and Newberry S.J. Systematic review of the effects of n-3 fatty acids in inflammatory bowel disease. Am J Clin Nutr 82 (2005) 611-619
76. Macdonald A. Omega-3 fatty acids as adjunctive therapy in Crohn's disease. Gastroenterol Nurs 29 (2006) 295-301
77. Romano C., Cucchiara S., and Barabino A. Usefulness of ω-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: a double-blind, randomized, placebo-controlled study. World J Gastroenterol 11 (2005) 7118-7121
78. Bousvaros A., Guandalini S., Baldassano R.N., Botelho C., Evans J., Ferry G.D., et al. A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease. Inflamm Bowel Dis 11 (2005) 833-839
79. Edozien J.C., Udo U.U., Young V.R., and Scrimshaw N.S. Effects of high levels of yeast feeding on uric acid metabolism of young man. Nature 228 (1970) 180
80. Boza J.J., Jahoor F., and Reeds P.J. Ribonucleic acid nucleotides in maternal and fetal tissues derive almost exclusively from synthesis de novo in pregnant mice. J Nutr 126 (1996) 1749-1758
81. Rueda R., Gomez-Leon C., and Gil A. Ribonucleic acid hydrolysis by intestinal explants of neonatal piglets. J Pediatr Gastroenterol Nutr 35 (2002) 685-690
82. Salati L.M., Gross C.J., Henderson L.M., and Saviano D.A. Absorption and metabolism of adenine, adenosine-5′-monophosphate, adenosine and hypoxanthine by the isolated vascularly perfused rat small intestine. J Nutr 114 (1984) 753-760
83. Carver J.D. Dietary nucleotides: effects on the immune and gastrointestinal systems. Acta Paediatr Suppl 88 (1999) 83-88
84. Ostrom K.M., Cordle C.T., Schaller J.P., Winship T.R., Thomas D.J., Jacobs J.R., et al. Immune status of infants fed soy-based formulas with or without added nucleotides for 1 year: part 1: vaccine responses, and morbidity. J Pediatr Gastroenterol Nutr 34 (2002) 137-144
85. Schaller J.P., Kuchan M.J., Thomas D.L., Cordle C.T., Winship T.R., Buck R.H., et al. Effect of dietary ribonucleotides on infant immune status. Part 1: humoral responses. Pediatr Res 56 (2004) 883-890
86. Pickering L.K., Granoff D.M., Erickson J.R., Masor M.L., Cordle C.T., Schaller J.P., et al. Modulation of the immune system by human milk and infant formula containing nucleotides. Pediatrics 101 (1998) 242-249
87. Grimble G.K. Nucleotides as immunomodulators in clinical nutrition. Curr Opin Clin Nutr Metab Care 4 (2001) 57-64
88. Yu V.Y. The role of dietary nucleotides in neonatal and infant nutrition. J Paediatr Child Health 38 (2002) 543-549
89. Yau K.I. Effect of nucleotides on diarrhea and immune responses in healthy term infants in Taiwan. J Pediatr Gastroenterol Nutr 36 (2003) 37-43
90. Buck R.H., Thomas D.L., Winship T.R., Cordle C.T., Kuchan M.J., Baggs G.E., et al. Effect of dietary ribonucleotides on infant immune status. Part 2: immune cell development. Pediatr Res 56 (2004) 891-900
91. Brunser O., Espinoza J., Araya M., Cruchet S., and Gil A. Effect of dietary nucleotide supplementation on diarrhoeal disease in infants. Acta Paediatr 83 (1994) 188-191
92. Carver J.D., Pimentel B., Cox W.I., and Barness L.A. Dietary nucleotide effects upon immune function in infants. Pediatrics 88 (1991) 359-363
93. Hawkes J.S., Gibson R.A., Roberton D., and Makrides M. Effect of dietary nucleotide supplementation on growth and immune function in term infants: a randomized controlled trial. Eur J Clin Nutr 60 (2006) 254-264
94. Cordle C.T., Winship T.R., Schaller J.P., Thomas D.J., Buck R.H., Ostrom K.M., et al. Immune status of infants fed soy-based formulas with or without added nucleotides for 1 year: part 2: immune cell populations. J Pediatr Gastroenterol Nutr 34 (2002) 145-153
95. Carver J.D., Saste M., Sosa R., Zaritt J., Kuchan M., and Barness L.A. The effects of dietary nucleotides on intestinal blood flow in preterm infants. Pediatr Res 52 (2002) 425-429
96. Carver J.D., Sosa R., Saste M., and Kuchan M. Dietary nucleotides and intestinal blood flow velocity in term infants. J Pediatr Gastroenterol Nutr 39 (2004) 38-42
97. Gibson R.A., Hawkes J.S., and Makrides M. Dietary nucleotides do not alter erythrocyte long-chain polyunsaturated fatty acids in formula-fed term infants. Lipids 40 (2005) 631-634
98. Barbosa E. Pilot study with a glutamine-supplemented enteral formula in critically ill infants. Rev Hosp Clin Fac Med Sao Paolo 54 (1999) 21-24
99. Van den Berg A., van Elburg R.M., Westerbeek E.A., van der Linde E.G., Knol J., Twisk J.W., and Fetter W.P. Glutamine-enriched enteral nutrition in very-low-birth-weight infants and effects on feeding tolerance and infectious morbidity: a randomized controlled trial. Am J Clin Nutr 81 (2005) 1397-1404
100. Tubman T.R., Thompson S.W., and McGuire W. Glutamine supplementation to prevent morbidity and mortality in preterm infants. Cochrane Database Syst Rev 1 (2005) CD001457.
101. Calder P.C. Polyunsaturated fatty acids, inflammation, and immunity. Lipids 36 (2001) 1007-1023
102. Calder P.C. Dietary modification of inflammation with lipids. Proc Nutr Soc 61 (2002) 345-358
103. Lawson L.D., and Hughes B.G. Human absorption of fish oil fatty acids as triacylglycerols, free acids, or ethyl esters. Biochem Biophys Res Commun 152 (1988) 328-335
104. Serhan C.N., Arita M., Hong S., and Gotlinger K. Resolvins, docosatrienes and neuroprotectins, novel omega-3 derived mediators, and their endogenous aspirin-triggered epimers. Lipids 39 (2004) 1125-1132
105. Healy D.A., Wallace F.A., Miles E.A., Calder P.C., and Newsholm P. Effect of low-to-moderate amounts of dietary fish oil on neutrophil lipid composition and function. Lipids 35 (2000) 763-768
106. Caughey G.E., Mantzioris E., Gibson R.A., Cleland L.G., and James M.J. The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 63 (1996) 116-122
107. Field C.J. Polyunsaturated fatty acids and T-cell function: implications for the neonate. Lipids 36 (2001) 1025-1032
108. Melnik B.C., and Plewig G. Is the origin of atopy linked to deficient conversion of omega-6-fatty acids to prostaglandin E1?. J Am Acad Dermatol 21 (1989) 557-563
109. Beck M., Zelczak G., and Lentze M.J. Abnormal fatty acid composition in umbilical cord blood of infants at high risk of atopic disease. Acta Paediatr 89 (2000) 279-284
110. Mihrshahi S., Peat J.K., Webb K., Tovey E.R., Marks G.B., Mellis C.M., and Leeder S.R. The childhood asthma prevention study (CAPS): design and research protocol of a randomized trial for the primary prevention of asthma. Control Clin Trials 22 (2001) 333-354
111. Wright S., and Bolton C. Breast milk fatty acids in mothers of children with atopic eczema. Br J Nutr 62 (1989) 693-697
112. Mihrshahi S., Peat J.K., Marks G.B., Tovey E.R., Marks G.B., Mellis C.M., and Leeder S.R. Childhood Asthma Prevention Study. Eighteen-month outcomes of house dust mite avoidance and dietary fatty acid modification in the Childhood Asthma Prevention Study (CAPS). J Allergy Clin Immunol 111 (2003) 162-168
113. Peat J.K., Mihrshahi S., Kemp A.S., Marks G.B., Tovey E.R., and Webb K. Three-year outcomes of dietary fatty acid modification and house dust mite reduction in the Childhood Asthma Prevention Study. J Allergy Clin Immunol 114 (2004) 807-813
114. Dunstan J.A., Mori T.A., Barden A., Beilin L.J., Taylor A.L., Holt P.G., and Prescott S.L. Maternal fish oil supplementation in pregnancy reduces interleukin-13 levels in cord blood of infants at high risk of atopy. Clin Exp Allergy 33 (2003) 442-448
115. Schappi M., Flack S., Hascke F., et al. Omega 3 PUFA enriched semi-elemental diet for protracted diarrhoea. J Pediatr Gastroenterol Nutr 42 suppl (2006) E39
116. Kuroki F., Iida M., Matsumoto T., Aoyagi K., Kanamoto K., and Fujishima M. Serum n-3 polyunsaturated fatty acids are depleted in Crohn's disease. Dig Dis Sci 42 (1997) 1137-1141
117. Holman R.T. Control of polyunsaturated fatty acids in tissue lipids. J Am Col Nutr 5 (1986) 183-211
118. Kremer J.M., Jubiz W., Michalek A., Rynes R.I., Bartholomew L.E., and Bigaouette J. Fish-oil fatty acid supplementation in active rheumatoid arthritis. A double-blinded, controlled, crossover study. Ann Intern Med 106 (1987) 497-503
119. Von Schacky C., Fisher S., and Weber P.C. Long-term effects of dietary marine n-3 fatty acids upon plasma and cellular lipids, platelet function and eicosanoid formation in humans. J Clin Invest 76 (1985) 1626-1631
120. Teitelbaum J.E., and Walker W.A. Review: the role of omega 3 fatty acids in intestinal inflammation. J Nutr Biochem 12 (2001) 21-32
121. Mc Call T.B., O' Leary D., Bloomfield J., and O'Moráin C.A. Therapeutic potential fish oil in the treatment of ulcerative colitis. Aliment Pharmacol Ther 3 (1989) 415-424
122. Salomon P., Kornbluth A.A., and Janowitz H.D. Treatment of ulcerative colitis with fish oil n-3-omega-fatty acid: an open trial. J Clin Gastroenterol 12 (1990) 157-161
123. Hawthorne A.B., Daneshemend T.K., and Hawkey C.J. Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut 33 (1992) 922-928
124. Strasser T., Fisher S., and Weber P.C. Leukotriene B5 is formed in human neutrophils after dietary supplementation with eicosapentaenoic acid. Proc Natl Acad Sci U S A 82 (1985) 1540-1543
125. Nielsen A.A., Jorgensen L.G., Nielsen J.N., Eivindson M., Grønbaek H., Vind I., et al. Omega-3 fatty acids inhibit an increase of proinflammatory cytokines in patients with active Crohn's disease compared with omega-6 fatty acids. Aliment Pharmacol Ther 22 (2005) 1121-1128
126. Lorenz-Meyer H., Bauer P., Nicolay C., Schulz B., Purrmann J., Fleig W.E., et al., Study Group Members (German Crohn's Disease Study Group). Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Scand J Gastroenterol 31 (1996) 778-785
127. Li D., Mann N.J., and Sinclair A.J. Comparison of n-3 polyunsaturated fatty acids from vegetable oils, meat, and fish in raising platelet eicosapentaenoic acid levels in humans. Lipids 34 (1999) S309
128. Mori T.A., Burke V., Puddey I.B., Watts G.F., O'Neal D.N., Best J.D., and Beilin L.J. Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr 71 (2000) 1085-1094
129. Morley R. Nutrition and cognitive development. Nutrition 14 (1998) 752-754
130. Simopoulos A.P., Leaf A., and Salem N. Workshop on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. J Am Coll Nutr 18 (1999) 487-489
131. ESPGHAN Committee on Nutrition, Aggett P.J., Agostoni C., Axelsson I., De Curtis M., Agostoni O., et al. Feeding preterm infants after hospital discharge: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 42 (2006) 596-603
132. Field C.L., Thomson C.A., Van Aerde J.E., Parrott A., Euler A., Lien E., and Clandinin M.T. Lower proportion of CD45R0_ cells and deficient interleukin-10 production by formula-fed infants, compared with human-fed, is corrected with supplementation of long-chain polyunsaturated fatty acids. J Pediatr Gastroenterol Nutr 31 (2000) 291-299
133. Isaacs C.E. Antimicrobial activity of lipids added to human milk, infant formula, and bovine milk. J Nutr Biochem 6 (1995) 362-366
134. Kono H., Fujii H., Asakawa M., Maki A., Amemiya H., Hirai Y., et al. Medium-chain triglycerides enhance secretory IgA expression in rat intestine after administration of endotoxin. Am J Physiol Gastrointest Liver Physiol 286 (2004) G1081-G1089
135. Gorard D.A. Enteral nutrition in Crohn's disease: fat in the formula. Eur J Gastroenterol Hepatol 15 (2003) 115-118
136. Klenoff-Brumberg H.L., and Genen L.H. High versus low medium chain triglyceride content of formula for promoting short term growth of preterm infants. Cochrane Database Syst Rev 1 (2003) CD002777.
137. Lutter C.K., and Rivera J.A. Nutritional status of infants and young children and characteristics of their diets. J Nutr 133 (2003) 2941S-2949
138. Sanchez-Grinan M.I. Effect of varied dietary fat and carbohydrate concentrations on total dietary daily energy intake by recovering malnourished children. FASEB J 9 (1995) A1007
139. Schoetzau A., Gehring U., Franke K., Grübl A., Koletzko S., and von Berg A. Maternal compliance with nutritional recommendations in an allergy preventive programme. Arch Dis Child 86 (2002) 180-184
140. Shepherd C.K., Power K.G., and Carter H. Characteristics of responders and non-responders in an infant feeding study. J Public Health Med 20 (1998) 275-280
141. Pöysä L., Remes K., Korppi M., and Launiala K. Compliance with a dietary manipulation programme in families with infants prone to atopy. Acta Paediatr Scand 77 (1988) 563-568
142. Hide D.W., Matthews S., Tariq S., and Arshad S.H. Allergen avoidance in infancy and allergy at 4 years of age. Allergy 51 (1996) 89-93
143. Fabiani E., Taccari L.M., Ratsch I.M., Di Giuseppe S., Coppa G.V., and Catassi C. Compliance with gluten-free diet in adolescents with screening-detected celiac disease: a 5 year follow up. J Pediatr 136 (2000) 841-843